Skip to content

Search across repositories

Find data for your analysis

602 datasets from 5 repositories. Filter by the analysis you need to run, not by what a repository says a dataset contains. How capability is measured.

258 of 602 datasets

  • MSK MetTropism (MSK, Cell 2021)
    OpenMachine-extracted
    msk_met_2021cBioPortal25,775 casesMixed Cancer Types

    Why it fits: survival endpoints, median follow-up 17.4 months; 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • MSK-CHORD (MSK, Nature 2024)
    OpenMachine-extracted
    msk_chord_2024cBioPortal24,950 casesMixed Cancer Types

    Why it fits: survival endpoints, median follow-up 2.1 years; 4 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panelTreatment records

    No citable accession, so reuse cannot be traced

  • MSK-IMPACT Clinical Sequencing Cohort (MSK, Nat Med 2017)
    OpenMachine-extracted
    msk_impact_2017cBioPortal10,336 casesMixed Cancer Types

    Why it fits: survival endpoints, median follow-up 11.0 months; 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • MSK ctDNA Sequencing Cohort (MSK, Nature Medicine 2024)
    OpenMachine-extracted
    msk_ctdna_vte_2024cBioPortal5,567 casesMixed Cancer Types

    Why it fits: 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Molecular Characterization Initiative (MCI)
    MixedMachine-extracted
    CCDI-MCIGDC + IDC4,407 casesCystic, Mucinous and Serous Neoplasms, Granular Cell Tumors and Alveolar Soft Part Sarcomas

    Why it fits: 3 measurement types on the same cohort

    DNA methylationRadiology imagingWhole exome sequencing

    1 article analyzed these data

  • Breast Cancer (MSK, Nat Genet 2025)
    OpenMachine-extracted
    breast_msk_2025cBioPortal3,116 casesInvasive Breast Carcinoma

    Why it fits: survival endpoints, median follow-up 3.3 years; 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Acute Myeloid Leukemia
    MixedProject-curated
    TARGET-AMLGDC2,492 casesMyeloid Leukemias, Not Applicable

    Why it fits: treatment response recorded; survival endpoints, median follow-up 3.5 years; 9 measurement types on the same cohort

    2,492 children and young adults with acute myeloid leukaemia - the largest paediatric cancer genomics cohort in this corpus, with 3.5 years of median follow-up and therapeutic agents recorded for 35% of cases.

    Clinical dataCopy numberDNA methylationmicroRNABulk RNA sequencingStructural variants+3 more

    137 articles analyzed these data - 695 cite the paper

  • Pancreatic Adenocarcinoma (MSK, Nat Med 2024)
    OpenMachine-extracted
    pdac_msk_2024cBioPortal2,336 casesPancreas

    Why it fits: survival endpoints, median follow-up 13.5 months; 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Lung Adenocarcinoma Met Organotropism (MSK, Cancer Cell 2023)
    OpenMachine-extracted
    luad_mskcc_2023_met_organotropismcBioPortal2,298 casesLung Adenocarcinoma

    Why it fits: survival endpoints, median follow-up 3.1 years; 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Prostate Cancer (MSK, Clin Cancer Res 2024)
    OpenMachine-extracted
    prostate_msk_2024cBioPortal2,257 casesProstate

    Why it fits: survival endpoints, median follow-up 3.5 years; 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Sarcoma (MSK, Nat Commun. 2022)
    OpenMachine-extracted
    sarcoma_mskcc_2022cBioPortal2,138 casesSoft Tissue

    Why it fits: survival endpoints, median follow-up 22.5 months; 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Race Differences in Prostate Cancer (MSK, 2021)
    OpenMachine-extracted
    prad_msk_stopsack_2021cBioPortal2,069 casesProstate Adenocarcinoma

    Why it fits: 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus
    Underused opportunityMixedProject-curated
    CPTAC-3GDC1,866 casesNot Applicable, Transitional Cell Papillomas and Carcinomas

    Why it fits: treatment response recorded; survival endpoints, median follow-up 22.9 months; 9 measurement types on the same cohort

    1,866 tumors across six cancer types with genomics in the GDC and proteomics in the PDC - the largest prospectively collected proteogenomic cohort, with recurrence recorded for 78% of cases.

    Copy numberDNA methylationmicroRNABulk RNA sequencingSingle-cell RNA sequencingStructural variants+3 more

    25 articles analyzed these data - 688 cite the paper

  • Breast Cancer (MSK, Cancer Cell 2018)
    OpenMachine-extracted
    breast_msk_2018cBioPortal1,756 casesBreast

    Why it fits: survival endpoints, median follow-up 3.4 years; 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Cancer Cell Line Encyclopedia (Broad, 2019)
    OpenMachine-extracted
    ccle_broad_2019cBioPortal1,739 casesMixed Cancer Types

    Why it fits: 5 measurement types on the same cohort; majority Caucasian; no access request needed

    Copy numberProteome (mass spectrometry)Bulk RNA sequencingStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Acute Lymphoblastic Leukemia - Phase II
    MixedMachine-extracted
    TARGET-ALL-P2GDC1,587 casesLymphoid Leukemias

    Why it fits: survival endpoints, median follow-up 7.7 years; 7 measurement types on the same cohort

    Clinical dataCopy numbermicroRNABulk RNA sequencingStructural variantsWhole genome sequencing+1 more

    42 articles analyzed these data

  • Colorectal Cancer (MSK, JNCI 2021)
    OpenMachine-extracted
    crc_eo_2020cBioPortal1,516 casesBowel

    Why it fits: 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia
    Underused opportunityMixedProject-curated
    MP2PRT-ALLGDC1,510 casesAcute Lymphoblastic Leukemia, Lymphoid Leukemias

    Why it fits: treatment response recorded; survival endpoints, median follow-up 8.3 years; 6 measurement types on the same cohort

    1,510 children with acute lymphoblastic leukaemia from Children's Oncology Group trials, with whole genome sequencing, 8.4 years of median follow-up, and a named treatment regimen and response recorded for every single case.

    Clinical dataCopy numberBulk RNA sequencingStructural variantsWhole genome sequencingWhole exome sequencing

    0 articles analyzed these data

  • Prostate Adenocarcinoma (MSK, Eur Urol 2020)
    OpenMachine-extracted
    prad_cdk12_mskcc_2020cBioPortal1,465 casesProstate Adenocarcinoma

    Why it fits: 4 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panelTreatment records

    No citable accession, so reuse cannot be traced

  • Prostate Adenocarcinoma (MSK, Clin Cancer Res. 2022)
    OpenMachine-extracted
    prad_pik3r1_msk_2021cBioPortal1,417 casesProstate Adenocarcinoma

    Why it fits: survival endpoints, median follow-up 2.2 years; 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Hepatocellular Carcinoma (MSK, Clin Cancer Res 2024)
    OpenMachine-extracted
    hcc_msk_2024cBioPortal1,370 casesHepatocellular Carcinoma

    Why it fits: survival endpoints, median follow-up 18.4 months; 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Hepatobiliary Cancer (MSK, 2026)
    OpenMachine-extracted
    biliary_tract_msk_2026cBioPortal1,254 casesBiliary Tract

    Why it fits: survival endpoints, median follow-up 10.6 months; 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Bladder Cancer (MSK, Cell Reports 2022)
    OpenMachine-extracted
    paired_bladder_2022cBioPortal1,244 casesBladder/Urinary Tract

    Why it fits: survival endpoints, median follow-up 2.6 years; 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial
    MixedMachine-extracted
    ALCHEMIST-ALCHGDC1,176 casesNot Reported

    Why it fits: 8 measurement types on the same cohort

    Clinical dataCopy numberHistopathology slidesmicroRNABulk RNA sequencingStructural variants+2 more

    0 articles analyzed these data

  • Chronic Lymphocytic Leukemia (Broad, Nature Genetics 2022)
    OpenMachine-extracted
    cll_broad_2022cBioPortal1,149 casesChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    Why it fits: survival endpoints, median follow-up 6.6 years; 4 measurement types on the same cohort; no access request needed

    Bulk RNA sequencingStructural variantsTargeted DNA panelTreatment records

    No citable accession, so reuse cannot be traced

  • Neuroblastoma
    MixedMachine-extracted
    TARGET-NBLGDC1,132 casesNot Applicable, Neuroepitheliomatous Neoplasms

    Why it fits: survival endpoints, median follow-up 6.2 years; 7 measurement types on the same cohort

    Clinical dataDNA methylationBulk RNA sequencingStructural variantsTargeted DNA panelWhole genome sequencing+1 more

    49 articles analyzed these data - 989 cite the paper

  • Metastatic Non-Small Cell Lung Cancer (MSK, Nature Medicine 2022)
    OpenMachine-extracted
    nsclc_ctdx_msk_2022cBioPortal1,127 casesNon-Small Cell Lung Cancer

    Why it fits: survival endpoints, median follow-up 16.6 months; 4 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panelTreatment records

    No citable accession, so reuse cannot be traced

  • Metastatic Breast Cancer (MSK, Cancer Discovery 2022)
    OpenMachine-extracted
    breast_ink4_msk_2021cBioPortal1,116 casesBreast

    Why it fits: 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Metastatic Colorectal Cancer (MSK, Cancer Cell 2018)
    OpenMachine-extracted
    crc_msk_2017cBioPortal1,099 casesColorectal Adenocarcinoma

    Why it fits: survival endpoints, median follow-up 2.4 years; 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Breast Invasive Carcinoma
    MixedProject-curated
    TCGA-BRCAGDC + IDC1,098 casesCystic, Mucinous and Serous Neoplasms, Adenomas and Adenocarcinomas

    Why it fits: treatment response recorded; survival endpoints, median follow-up 2.3 years; 12 measurement types on the same cohort

    1,098 breast tumors measured twelve ways across GDC and IDC, with treatment outcome on 64% of cases - the most reused dataset in this corpus and still the reference cohort for method development.

    ATAC sequencingClinical dataCopy numberHistopathology slidesDNA methylationmicroRNA+6 more

    2,373 articles analyzed these data - 9,914 cite the paper

  • Adenoid Cystic Carcinoma Project (J Clin Invest 2019)
    OpenMachine-extracted
    acc_2019cBioPortal1,045 casesAdenoid Cystic Carcinoma

    Why it fits: survival endpoints, median follow-up 4.1 years; 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Cancer Cell Line Encyclopedia (Novartis/Broad, Nature 2012)
    OpenMachine-extracted
    cellline_ccle_broadcBioPortal1,020 casesMixed Cancer Types

    Why it fits: 3 measurement types on the same cohort; no access request needed

    Copy numberBulk RNA sequencingTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Prostate Adenocarcinoma (MSK/DFCI, Nature Genetics 2018)
    OpenMachine-extracted
    prad_p1000cBioPortal1,013 casesProstate Adenocarcinoma

    Why it fits: 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Multiple Myeloma CoMMpass Study
    MixedMachine-extracted
    MMRF-COMMPASSGDC995 casesPlasma Cell Tumors

    Why it fits: survival endpoints, median follow-up 2.1 years; 5 measurement types on the same cohort

    Copy numberBulk RNA sequencingStructural variantsWhole genome sequencingWhole exome sequencing

    125 articles analyzed these data

  • GTEx
    OpenMachine-extracted
    gtexIDC971 casesNon-diseased

    Why it fits: 3 measurement types on the same cohort; no access request needed

    Clinical dataRadiology imagingWhole genome sequencing

    No citable accession, so reuse cannot be traced

  • Glioma (MSK, Clin Cancer Res 2019)
    OpenMachine-extracted
    glioma_mskcc_2019cBioPortal924 casesDiffuse Glioma

    Why it fits: survival endpoints, median follow-up 20.3 months; 4 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panelTreatment records

    No citable accession, so reuse cannot be traced

  • Duke-Breast-Cancer-MRI
    OpenMachine-extracted
    duke_breast_cancer_mriIDC922 casesBreast Cancer

    Why it fits: 3 measurement types on the same cohort; no access request needed

    Clinical dataRadiology imagingWhole genome sequencing

    No citable accession, so reuse cannot be traced

  • PDXNet
    OpenMachine-extracted
    pdxnetIDC919 casesAcinar Cell Carcinoma, Adrenal Cortical Carcinoma

    Why it fits: 3 measurement types on the same cohort; no access request needed

    Clinical dataRadiology imagingWhole genome sequencing

    No citable accession, so reuse cannot be traced

  • Esophagogastric Cancer (MSK, J Natl Cancer Inst 2023)
    OpenMachine-extracted
    egc_msk_2023cBioPortal902 casesEsophagus/Stomach

    Why it fits: survival endpoints, median follow-up 21.1 months; 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Pediatric Acute Myeloid Leukemia (St. Jude, Nat Genet 2024)
    OpenMachine-extracted
    aml_stjude_2024cBioPortal887 casesAcute Myeloid Leukemia

    Why it fits: 3 measurement types on the same cohort; no access request needed

    Bulk RNA sequencingStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced